AstraZeneca PLC (AZNN) — Cash Flow Reinvestment Rate
AstraZeneca PLC (AZNN) has a Cash Flow Reinvestment Rate of 0.55x as of December 2025, reinvesting MX$1.29 Billion (capex MX$1.29 Billion plus investments MX$-2.00 Million) from operating cash flow of MX$2.34 Billion. Check AZNN cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
AstraZeneca PLC Cash Flow Reinvestment Rate (2014–2025)
Historical reinvestment intensity for AstraZeneca PLC across 12 annual periods. Explore AstraZeneca PLC (AZNN) investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for AstraZeneca PLC (2014–2025)
Year-by-year capital reinvestment analysis for AstraZeneca PLC. For live market cap and broader valuation context, see market value of AstraZeneca PLC.
| Year | Reinvestment Rate | Total Reinvested (MXN) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.41x | MX$6.00 Billion | MX$14.57 Billion | MX$5.91 Billion | ▲ +6.2% |
| 2024 | 0.39x | MX$4.60 Billion | MX$11.86 Billion | MX$4.59 Billion | ▼ -39.3% |
| 2023 | 0.64x | MX$6.62 Billion | MX$10.36 Billion | MX$3.39 Billion | ▲ +407.9% |
| 2022 | 0.13x | MX$1.23 Billion | MX$9.81 Billion | MX$1.09 Billion | ▼ -55.8% |
| 2021 | 0.28x | MX$1.70 Billion | MX$5.96 Billion | MX$1.09 Billion | ▼ -53.9% |
| 2020 | 0.62x | MX$2.96 Billion | MX$4.80 Billion | MX$961.00 Million | ▲ +65.9% |
| 2019 | 0.37x | MX$1.10 Billion | MX$2.97 Billion | MX$979.00 Million | ▼ -17.7% |
| 2018 | 0.45x | MX$1.18 Billion | MX$2.62 Billion | MX$1.04 Billion | ▼ -8.8% |
| 2017 | 0.50x | MX$1.77 Billion | MX$3.58 Billion | MX$1.33 Billion | ▼ -67.3% |
| 2016 | 1.52x | MX$6.28 Billion | MX$4.14 Billion | MX$2.31 Billion | ▲ +214.5% |
| 2015 | 0.48x | MX$1.60 Billion | MX$3.32 Billion | MX$1.33 Billion | ▲ +204.0% |
| 2014 | 0.16x | MX$1.12 Billion | MX$7.06 Billion | MX$1.01 Billion | — |